Drug Trial Radar · NCT07812090
A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Aug 21, 2026
Primary completion
Nov 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- BioAge Labs, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 10, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to learn about the effects of BGE-102 on change in vision in participants with center-involved diabetic macular edema (CI-DME). BGE-102 decreases inflammation which may improve vision or slow the progression of vison loss in those with CI-DME. Participants will be randomized to one of 3 arms and receive either BGE-102 in combination with an anti-vascular endothelial growth factor (anti-VEGF) drug, BGE-102 in combination with sham injection, or BGE-102 placebo in combination with an anti-VEGF drug. This study will also evaluate safety and tolerability of BGE-102.
Conditions
- Diabetic Macular Edema (DME)
Interventions
Oral BGE-102Drug
Capsules
Oral Placebo Matching BGE-102Drug
Capsules
Anti-VEGFDrug
intravitreal injection
ShamOther
intravitreal injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Best Corrected Visual Acuity (BCVA)Time frame: Week 12
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Site 104
Bakersfield, California · Recruiting
Site 105
Glendale, California · Recruiting
Site 118
Mountain View, California · Recruiting
Site 128
Fort Myers, Florida · Recruiting
Site 113
South Miami, Florida · Recruiting
Site 119
West Monroe, Louisiana · Recruiting
Site 117
Cary, North Carolina · Recruiting
Site 116
Wake Forest, North Carolina · Recruiting
Site 101
Ladson, South Carolina · Recruiting
Site 111
Abilene, Texas · Recruiting
Site 129
Austin, Texas · Recruiting
Site 130
Houston, Texas · Recruiting
Site 125
Laredo, Texas · Recruiting
Site 106
McAllen, Texas · Recruiting
Site 110
San Antonio, Texas · Recruiting
Site 108
The Woodlands, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.